TY  - GEN
AU  - Baig,Nisar A
AU  - Taylor,Ronald P
AU  - Lindorfer,Margaret A
AU  - Church,Amy K
AU  - LaPlant,Betsy R
AU  - Pettinger,Adam M
AU  - Shanafelt,Tait D
AU  - Nowakowski,Grzegorz S
AU  - Zent,Clive S
TI  - Induced resistance to ofatumumab-mediated cell clearance mechanisms, including complement-dependent cytotoxicity, in chronic lymphocytic leukemia
SN  - 1550-6606
PY  - 2014///0414
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Alemtuzumab
KW  - Antibodies, Monoclonal
KW  - blood
KW  - Antibodies, Monoclonal, Humanized
KW  - therapeutic use
KW  - Antigens, CD
KW  - biosynthesis
KW  - Antigens, CD20
KW  - Antigens, Neoplasm
KW  - Antineoplastic Agents
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - B-Lymphocytes
KW  - cytology
KW  - CD52 Antigen
KW  - Complement System Proteins
KW  - metabolism
KW  - Cyclophosphamide
KW  - Cytotoxicity, Immunologic
KW  - immunology
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Glycoproteins
KW  - Humans
KW  - Leukemia, Lymphocytic, Chronic, B-Cell
KW  - drug therapy
KW  - Lymphocyte Count
KW  - Male
KW  - Middle Aged
KW  - Pentostatin
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.4049/jimmunol.1302954
ER  -